RU2013128360A - Her2-связывающие белки, меченые 18f-содержащим кремнийорганическим соединением - Google Patents
Her2-связывающие белки, меченые 18f-содержащим кремнийорганическим соединением Download PDFInfo
- Publication number
- RU2013128360A RU2013128360A RU2013128360/10A RU2013128360A RU2013128360A RU 2013128360 A RU2013128360 A RU 2013128360A RU 2013128360/10 A RU2013128360/10 A RU 2013128360/10A RU 2013128360 A RU2013128360 A RU 2013128360A RU 2013128360 A RU2013128360 A RU 2013128360A
- Authority
- RU
- Russia
- Prior art keywords
- polypeptide
- seq
- conjugated
- reacting
- silicon fluoride
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/975,425 | 2010-12-22 | ||
US12/975,425 US20120165650A1 (en) | 2010-12-22 | 2010-12-22 | Her2 binders |
US201161438297P | 2011-02-01 | 2011-02-01 | |
US61/438,297 | 2011-02-01 | ||
US201161510520P | 2011-07-22 | 2011-07-22 | |
US61/510,520 | 2011-07-22 | ||
US201161541314P | 2011-09-30 | 2011-09-30 | |
US61/541,314 | 2011-09-30 | ||
PCT/US2011/065803 WO2012087912A1 (fr) | 2010-12-22 | 2011-12-19 | Peptides de liaison à her2 marqués par un composé organosilicium contenant 18f |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2013128360A true RU2013128360A (ru) | 2015-01-27 |
Family
ID=45464124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013128360/10A RU2013128360A (ru) | 2010-12-22 | 2011-12-19 | Her2-связывающие белки, меченые 18f-содержащим кремнийорганическим соединением |
Country Status (13)
Country | Link |
---|---|
US (1) | US20130295010A1 (fr) |
EP (1) | EP2661284A1 (fr) |
JP (1) | JP2014503547A (fr) |
KR (1) | KR20130132939A (fr) |
CN (1) | CN103402550B (fr) |
AU (1) | AU2011349486A1 (fr) |
BR (1) | BR112013015798A2 (fr) |
CA (1) | CA2822698A1 (fr) |
MX (1) | MX2013007363A (fr) |
NZ (1) | NZ612327A (fr) |
RU (1) | RU2013128360A (fr) |
SG (1) | SG191338A1 (fr) |
WO (1) | WO2012087912A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120165650A1 (en) | 2010-12-22 | 2012-06-28 | General Electric Company | Her2 binders |
MX2013007365A (es) * | 2010-12-22 | 2013-09-26 | Ge Healthcare Ltd | Péptidos de enlace her2 etiquetados con fluoruro de aluminio- [18] combinados mediante nota. |
GB201209082D0 (en) * | 2012-05-24 | 2012-07-04 | Ge Healthcare Ltd | Purification method |
BR112015032211A2 (pt) | 2013-06-27 | 2017-08-29 | Ge Healthcare Ltd | Método para monitorar resposta à inibição de hsp90, e, uso de um polipeptídeo isolado conjugado com 18f |
GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
GB201322456D0 (en) | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
GB201322451D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Purification method and compositions |
FI3917626T3 (fi) * | 2019-01-30 | 2023-08-17 | Univ Muenchen Tech | Psma:ta sitova kaksimuotoinen radiomerkkiaine ja terapeuttinen aine |
CN110251695B (zh) * | 2019-07-10 | 2021-12-21 | 莎穆(上海)生物科技有限公司 | 一种靶向her2的放射性配合物及其制备方法和应用 |
CN114317385B (zh) * | 2021-11-11 | 2024-02-13 | 元本(珠海横琴)生物科技有限公司 | 一种促进her2亲和体蛋白分泌表达的发酵培养基及发酵工艺 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0305704D0 (en) | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
DE602004018141D1 (de) * | 2003-07-04 | 2009-01-15 | Affibody Ab | Polypeptide mit bindungsaffinität für her2 |
GB0428012D0 (en) | 2004-12-22 | 2005-01-26 | Hammersmith Imanet Ltd | Radiolabelling methods |
WO2008049866A1 (fr) * | 2006-10-27 | 2008-05-02 | Affibody Ab | Nouveau composé chélateur |
WO2008118601A2 (fr) * | 2007-02-27 | 2008-10-02 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Molécules d'anticorps radiomarqué |
EP2072525A1 (fr) * | 2007-12-21 | 2009-06-24 | Affibody AB | Nouveaux polypeptides présentant une affinité de liaison pour HER2 |
-
2011
- 2011-12-19 AU AU2011349486A patent/AU2011349486A1/en not_active Abandoned
- 2011-12-19 WO PCT/US2011/065803 patent/WO2012087912A1/fr active Application Filing
- 2011-12-19 US US13/996,142 patent/US20130295010A1/en not_active Abandoned
- 2011-12-19 CA CA2822698A patent/CA2822698A1/fr not_active Abandoned
- 2011-12-19 NZ NZ61232711A patent/NZ612327A/en not_active IP Right Cessation
- 2011-12-19 JP JP2013546280A patent/JP2014503547A/ja active Pending
- 2011-12-19 EP EP11805725.6A patent/EP2661284A1/fr not_active Withdrawn
- 2011-12-19 MX MX2013007363A patent/MX2013007363A/es unknown
- 2011-12-19 KR KR1020137019120A patent/KR20130132939A/ko not_active Application Discontinuation
- 2011-12-19 SG SG2013048830A patent/SG191338A1/en unknown
- 2011-12-19 RU RU2013128360/10A patent/RU2013128360A/ru not_active Application Discontinuation
- 2011-12-19 CN CN201180068115.9A patent/CN103402550B/zh not_active Expired - Fee Related
- 2011-12-19 BR BR112013015798A patent/BR112013015798A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20130295010A1 (en) | 2013-11-07 |
EP2661284A1 (fr) | 2013-11-13 |
AU2011349486A1 (en) | 2013-07-25 |
CA2822698A1 (fr) | 2012-06-28 |
CN103402550A (zh) | 2013-11-20 |
NZ612327A (en) | 2015-03-27 |
JP2014503547A (ja) | 2014-02-13 |
SG191338A1 (en) | 2013-07-31 |
BR112013015798A2 (pt) | 2019-09-24 |
WO2012087912A1 (fr) | 2012-06-28 |
CN103402550B (zh) | 2015-12-09 |
MX2013007363A (es) | 2013-09-26 |
KR20130132939A (ko) | 2013-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2013128360A (ru) | Her2-связывающие белки, меченые 18f-содержащим кремнийорганическим соединением | |
RU2013128361A (ru) | Her2-связывающие белки, меченые комплексом 18f-фторида алюминия и nota | |
US20230340020A1 (en) | Peptide ligands for binding to mt1-mmp | |
JP6942147B2 (ja) | Mt1−mmpに対して特異的な二環式ペプチド−毒素コンジュゲート | |
JP7148401B2 (ja) | 免疫調節剤としての複素環化合物 | |
JP7175887B2 (ja) | ジスルフィド含有細胞膜透過ペプチド並びにその製造方法及び使用方法 | |
AU2016265845B2 (en) | Chimeric antigen receptor compositions | |
JP6164556B2 (ja) | 非特異的腎集積が低減された放射性標識ポリペプチド作製用薬剤 | |
JP2016196472A5 (fr) | ||
RU2017144606A (ru) | Иммуноцитокины на основе il-15 и il-15rа домена sushi | |
JP2012100677A5 (fr) | ||
PE20120415A1 (es) | Anticuerpos anti-igf | |
RU2016130933A (ru) | Сульфонамид-содержащие связывающие системы для лекарственных конъюгатов | |
JP2014506135A5 (fr) | ||
JP2021528430A (ja) | Psmaに結合するためのペプチドリガンド | |
JP2009541288A5 (fr) | ||
JP2021528434A (ja) | インテグリンαvβ3に結合するためのペプチドリガンド | |
KR102590042B1 (ko) | 항체 약물 결합체에 사용되는 약물-링커 mc-mmaf의 제조 방법 및 이의 중간체 | |
US20210122804A1 (en) | Peptide ligands for binding to cd38 | |
JP2017502946A5 (fr) | ||
RU2013122649A (ru) | Способ радиоактивного коньюгирования | |
JP2010521441A5 (fr) | ||
RU2013111675A (ru) | Рекомбинантный fc-гибридный белок пятого домена фибронектина типа iii dcc | |
JP2014500883A5 (fr) | ||
JP2017501152A5 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20160603 |